When a nanoparticle (NP) is introduced into a biological
environment,
its identity and interactions are immediately attributed to the dense
layer of proteins that quickly covers the particle. The formation
of this layer, dubbed the protein corona, is in general a combination
of proteins interacting with the surface of the NP and a contest between
other proteins for binding sites either at the surface of the NP or
upon the dense layer. Despite the importance for surface engineering
and drug development, the molecular mechanisms and structure behind
interfacial biomolecule action have largely remained elusive. We use
ultrafast sum frequency scattering (SFS) spectroscopy to determine
the structure and the mode of action by which these biomolecules interact
with and manipulate interfaces. The majority of work in the field
of sum frequency generation has been done on flat model interfaces.
This limits some important membrane properties such as membrane fluidity
and dimensionalityimportant factors in biomolecule–membrane
interactions. To move toward three-dimensional (3D) nanoscopic interfaces,
we utilize SFS spectroscopy to interrogate the surface of 3D lipid
monolayers, which can be used as a model lipid-based nanocarrier system.
In this study, we have utilized SFS spectroscopy to follow the action
of lysozyme. SFS spectra in the amide I region suggest that there
is lysozyme at the interface and that the lysozyme induces an increased
lipid monolayer order. The binding of lysozyme with the NP is demonstrated
by an increase in acyl chain order determined by the ratio of the
CH3 symmetric and CH2 symmetric peak amplitudes.
Furthermore, the lipid headgroup orientation s-PO2
– change strongly supports lysozyme insertion into the
lipid layer causing lipid disruption and reorientation. Altogether,
with SFS, we have made a huge stride toward understanding the binding
and structure change of proteins within the protein corona.